| Application no. and date | 20713934.6 (espacenet) (Federated) (European Patent Register), 20200401 | | Patent/reg. no. and date | DK/EP 3946255, 20241120 | | Publication date | 20220209 | | Priority no. and date | WO PCT/EP2019/058635, 20190405 | | EP pub. no. and date |
EP 3946255 20220209 | | Effective date | | | Applicant/owner | BioNTech SE, An der Goldgrube 12
55131 Mainz, DE | | Applicant ref. no. | V2411-028-DK | | Inventor | HAAS, Heinrich, c/o BioNTech SE
An der Goldgrube 12
55131 Mainz, DE,
HÖRNER, Sebastian, c/o BioNTech SE
An der Goldgrube 12
55131 Mainz, DE,
HILLER, Thomas Michael, c/o BioNTech SE
An der Goldgrube 12
55131 Mainz, DE | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 9/00 (2006.01) , A61K 9/08 (2006.01) , A61K 9/127 (2006.01) , A61K 9/19 (2006.01) | | Title | FREMSTILLING OG OPBEVARING AF LIPOSOMALE RNA-FORMULERINGER, DER ER EGNEDE TIL TERAPI | | Int. application no. | EP2020059308 | | Int. publication no. | WO2020201383 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
